485 related articles for article (PubMed ID: 28297025)
21. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
[TBL] [Abstract][Full Text] [Related]
22. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
[TBL] [Abstract][Full Text] [Related]
23. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
24. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
25. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
Boileau I; Houle S; Rusjan PM; Furukawa Y; Wilkins D; Tong J; Selby P; Wilson AA; Kish SJ
Synapse; 2010 Jun; 64(6):417-20. PubMed ID: 20169578
[TBL] [Abstract][Full Text] [Related]
26. Decreased dopamine activity predicts relapse in methamphetamine abusers.
Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.
Groman SM; Lee B; Seu E; James AS; Feiler K; Mandelkern MA; London ED; Jentsch JD
J Neurosci; 2012 Apr; 32(17):5843-52. PubMed ID: 22539846
[TBL] [Abstract][Full Text] [Related]
28. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.
Johanson CE; Frey KA; Lundahl LH; Keenan P; Lockhart N; Roll J; Galloway GP; Koeppe RA; Kilbourn MR; Robbins T; Schuster CR
Psychopharmacology (Berl); 2006 Apr; 185(3):327-38. PubMed ID: 16518646
[TBL] [Abstract][Full Text] [Related]
29. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
[TBL] [Abstract][Full Text] [Related]
30. Modulation of striatal dopamine dynamics by cocaine self-administration and amphetamine treatment in female rats.
Siciliano CA; Mauterer MI; Fordahl SC; Jones SR
Eur J Neurosci; 2019 Aug; 50(4):2740-2749. PubMed ID: 31111573
[TBL] [Abstract][Full Text] [Related]
31. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
Schneier FR; Abi-Dargham A; Martinez D; Slifstein M; Hwang DR; Liebowitz MR; Laruelle M
Depress Anxiety; 2009; 26(5):411-8. PubMed ID: 19180583
[TBL] [Abstract][Full Text] [Related]
32. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
33. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
[TBL] [Abstract][Full Text] [Related]
34. Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys.
Berro LF; Perez Diaz M; Maltbie E; Howell LL
Psychopharmacology (Berl); 2017 Sep; 234(17):2607-2617. PubMed ID: 28584928
[TBL] [Abstract][Full Text] [Related]
35. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic system dysfunction in recreational dexamphetamine users.
Schrantee A; Václavů L; Heijtel DF; Caan MW; Gsell W; Lucassen PJ; Nederveen AJ; Booij J; Reneman L
Neuropsychopharmacology; 2015 Mar; 40(5):1172-80. PubMed ID: 25394786
[TBL] [Abstract][Full Text] [Related]
37. Developing Treatments for Stimulant Abuse: A Brief Overview.
Davidson C
East Asian Arch Psychiatry; 2016 Jun; 26(2):52-9. PubMed ID: 27377486
[TBL] [Abstract][Full Text] [Related]
38. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
Wang GJ; Volkow ND; Wigal T; Kollins SH; Newcorn JH; Telang F; Logan J; Jayne M; Wong CT; Han H; Fowler JS; Zhu W; Swanson JM
PLoS One; 2013; 8(5):e63023. PubMed ID: 23696790
[TBL] [Abstract][Full Text] [Related]
39. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
Cervinski MA; Foster JD; Vaughan RA
J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
[TBL] [Abstract][Full Text] [Related]
40. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
McCann UD; Wong DF; Yokoi F; Villemagne V; Dannals RF; Ricaurte GA
J Neurosci; 1998 Oct; 18(20):8417-22. PubMed ID: 9763484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
